The present invention relates to a tablet dosage form of a proton pump inhibitor. The tablet dosage form comprise at least two fractions of proton pump inhibitor wherein the two fractions are designed such that there occurs delayed release of the proton pump inhibitor based on specific pH of the environment in the gastrointestinal tract and wherein first fraction releases at about a first pH and the second fraction of the proton pump inhibitor releases at about a second pH.